On Sept. 30, hours before the federal government shut down, the U.S. Food and Drug Administration had a baffling act to fit in. The FDA stealthily approved a new generic version of the abortion drug mifepristone. Mifepristone, a drug the FDA itself admits sends as many as 1 in 25 women to the emergency room even under strict use conditions, is not […]
Source